ARS Pharmaceuticals Inc banner

Multiples-Based Value

The Multiples-Based Value for ARS Pharmaceuticals Inc (SPRY) under the Base Case is 12.69 USD. Compared with the current market price of 4.23 USD, the stock appears Undervalued by 67% .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SPRY Multiples-Based Value
Base Case
$12.69
Undervaluation 67%
Multiples-Based Value
Price $4.23

Multiples Across Competitors

SPRY Competitors Multiples
ARS Pharmaceuticals Inc Competitors